Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome
Pediatric Nephrology · 2024
DOI: 10.1007/s00467-024-06342-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Nephrology, 2024. Verfasst von Shuichiro Fujinaga. Beteiligte Einrichtung: Division of Nephrology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-Ku, Saitama-city, Saitama, 330-8777, Japan. f_shuich@d2.dion.ne.jp. Hauptthemen laut MEDLINE: Rituximab, Nephrotic Syndrome, Recurrence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben. Gefördert von: Grants-in-Aid for research from Saitama Children's Medical Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-Ku, Saitama-city, Saitama, 330-8777, Japan. f_shuich@d2.dion.ne.jp.
ORCID-Profile: Shuichiro Fujinaga
Förderung
- Grants-in-Aid for research from Saitama Children's Medical Center
Zitieren
APA
Fujinaga, S. (2024). Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06342-4
Vancouver
Fujinaga S. Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome. Pediatric Nephrology. 2024. doi:10.1007/s00467-024-06342-4
BibTeX
@article{Fujinaga2024,
author = {Fujinaga, Shuichiro},
title = {Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndrome},
journal = {Pediatric Nephrology},
year = {2024},
doi = {10.1007/s00467-024-06342-4}
}
EUVIMED